Basis: Trailing twelve months (TTM net income over the latest quarterly balance sheet). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on assets (ROA) high or low?
The return on assets (ROA) of 0.62% is 87% below its 5-year average of 4.82%, near the low end of its 5-year range (-1.07%–14.60%).
88.41% below its 12-month average of 5.35%.
Reported quarterly return on assets; no daily interpolation. Q2 FY2026 (2026-06-30): 0.38%.
RETURN ON ASSETS (ROA)
0.62%
RETURN ON ASSETS (ROA) AVG TTM
5.35%
RETURN ON ASSETS (ROA) AVG 3Y
3.84%
RETURN ON ASSETS (ROA) AVG 5Y
4.82%
RETURN ON ASSETS (ROA) AVG 10Y
0.35%
RETURN ON ASSETS (ROA) AVG 15Y
-1.39%
RETURN ON ASSETS (ROA) AVG 20Y
-2.23%
CURRENT VS TTM AVG
-88.41%
CURRENT VS 3Y AVG
-83.86%
CURRENT VS 5Y AVG
-87.13%
CURRENT VS 10Y AVG
+77.14%
CURRENT VS 15Y AVG
+144.65%
CURRENT VS 20Y AVG
+127.78%
SECTOR MEDIAN · HEALTHCARE
-24.95%
median of 444 covered companies
CURRENT VS SECTOR MEDIAN
+102.48%
vs the sector median at left
BioMarin Pharmaceutical Inc.
Market Cap
$11.12B
Return on Assets (ROA)
0.62%
TTM Avg
5.35%
3Y Avg
3.84%
5Y Avg
4.82%
Market Cap
$11.07B
Return on Assets (ROA)
4.50%
TTM Avg
3.10%
3Y Avg
3.02%
5Y Avg
7.71%
Market Cap
$11.36B
Return on Assets (ROA)
7.03%
TTM Avg
4.83%
3Y Avg
6.67%
5Y Avg
7.46%
Market Cap
$10.87B
Return on Assets (ROA)
-157.89%
TTM Avg
-89.00%
3Y Avg
-102.14%
5Y Avg
-97.13%
Market Cap
$10.66B
Return on Assets (ROA)
9.58%
TTM Avg
8.61%
3Y Avg
6.84%
5Y Avg
6.99%
Market Cap
$10.33B
Return on Assets (ROA)
9.76%
TTM Avg
6.05%
3Y Avg
5.92%
5Y Avg
6.23%
Market Cap
$12.00B
Return on Assets (ROA)
8.33%
TTM Avg
7.48%
3Y Avg
6.38%
5Y Avg
5.99%
Market Cap
$10.22B
Return on Assets (ROA)
2.17%
TTM Avg
-6.26%
3Y Avg
-11.14%
5Y Avg
1.46%
| NAME | MARKET CAP | RETURN ON ASSETS (ROA) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| BioMarin Pharmaceutical Inc. (BMRN) | $11.12B | 0.62% | 5.35% | 3.84% | 4.82% |
| The Cooper Companies, Inc. (COO)vs › | $11.07B | 4.50% | 3.10% | 3.02% | 7.71% |
| Bio-Techne Corporation (TECH)vs › | $11.36B | 7.03% | 4.83% | 6.67% | 7.46% |
| ImmunityBio, Inc. (IBRX)vs › | $10.87B | -157.89% | -89.00% | -102.14% | -97.13% |
| DaVita Inc. (DVA)vs › | $11.47B | 4.79% | 4.84% | 4.27% | 4.56% |
| Universal Health Services, Inc. (UHS)vs › | $10.66B | 9.58% | 8.61% | 6.84% | 6.99% |
| Globus Medical, Inc. (GMED)vs › | $10.33B | 9.76% | 6.05% | 5.92% | 6.23% |
| Encompass Health Corporation (EHC)vs › | $12.00B | 8.33% | 7.48% | 6.38% | 5.99% |
| Bio-Rad Laboratories, Inc. (BIO)vs › | $10.22B | 2.17% | -6.26% | -11.14% | 1.46% |
| Molina Healthcare, Inc. (MOH)vs › | $10.13B | -0.04% | 5.29% | 6.08% | 6.13% |
ROA
0.6%
ROE
1.1%
ROA = Net Income / Total Assets
Return on assets measures how efficiently a company generates profit from its total assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON ASSETS (ROA) |
|---|---|
| 2025-12-31 | 4.59% |
| 2024-12-31 | 6.11% |
| 2023-12-31 | 2.45% |
| 2022-12-31 | 2.22% |
| 2021-12-31 | -1.07% |
| 2020-12-31 | 14.60% |
| 2019-12-31 | -0.51% |
| 2018-12-31 | -1.74% |
| 2017-12-31 | -2.53% |
| 2016-12-31 | -15.66% |
| 2015-12-31 | -4.61% |
| 2014-12-31 | -5.41% |
| 2013-12-31 | -7.86% |
| 2012-12-31 | -7.29% |
| 2011-12-31 | -4.12% |
| 2010-12-31 | 16.30% |
| 2009-12-31 | -0.05% |
| 2008-12-31 | 3.40% |
| 2007-12-31 | -1.94% |
| 2006-12-31 | -6.16% |
| 2005-12-31 | -38.03% |
| 2004-12-31 | -80.46% |
| 2003-12-31 | -29.57% |
| 2002-12-31 | -70.03% |
| 2001-12-31 | -39.35% |
| 2000-12-31 | -48.57% |
| 1999-12-31 | -27.11% |
| 1998-12-31 | -39.04% |
